Home > Specialties > Reagents, Molecular Assay, Gene Expression, Cancer Recurrence, Breast

Reagents, Molecular Assay, Gene Expression, Cancer Recurrence, Breast

Definition : Cancer recurrence gene expression molecular assay reagents intended to determine the level at which certain genes are expressed (i.e., the gene activity) in a breast cancer tumor tissue sample. The tissue sample is analyzed to determine the presence or levels of nucleic acids, proteins, and/or other molecular products by one or more of a variety of methods, such as reverse transcription-polymerase chain reaction (RT-PCR), fluorescent in-situ hybridization (FISH), or microarray analysis. The overexpression or underexpression of these genes may be associated with the likelihood of breast cancer recurrence. Breast cancer recurrence expression analysis tests also may be used to determine appropriate (e.g., drug-specific) treatment and/or identify the tissue of origin for tumors with unclear pathology. Some tests give a recurrence score that predicts the chance of the cancer returning within a given period (e.g., 10 years) of the original diagnosis.

Entry Terms : "Oncotype DX Molecular Assays, Breast" , "Breast Cancer Recurrence Oncotype DX Molecular Assays" , "Breast Cancer Recurrence Gene Expression Reagents"

UMDC code : 27000

   

1-4 of 4 Match(es).

Agendia bv

Agendia bv

Agendia Inc USA

We are a commercial-stage molecular diagnostic company, focused on the discovery, development and commercialisation of innovative products to improve the quality of life for cancer patients by providing healthcare professionals with critical information to enable safe and effective personalised treatment. We are currently marketing our Symphony™ suite of four complementary breast cancer tests, of which two currently generate revenue, with a strong focus on the US market.

Genomic Health Inc

Genomic Health, a molecular diagnostics company founded in August of 2000 and located in Redwood City, California, is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services.

Sysmex Europe GmbH

Sysmex Europe GmbH

1-4 of 4 Match(es).

 

Medical Product Guide Optometric Management Product Guide